Summary
Chembio Diagnostics Inc (Chembio) develops, manufactures, markets and licenses point-of-care diagnostic (POCs) tests for the detection of infectious diseases. The company offers products prevent the spread of infectious diseases with solutions like Chembio Dual Path Platform (DPP), which makes POC testing faster. Its DPP technology uses to treat infectious diseases such as HIV, Ebola, syphilis, malaria and febrile illness. The company offers its products to medical laboratories and hospitals, non-governmental organizations, governmental and public health entities, medical professionals and retailers. It also offers veterinary diagnostics. The company distributes its products through a network of distributors worldwide. Chembio is headquartered in Medford, the US.
Chembio Diagnostics Inc (CEMI) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Chembio Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Chembio Diagnostics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Chembio Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Chembio Diagnostics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Chembio Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Chembio Diagnostics Inc, Medical Equipment, Deal Details 11
Partnerships 11
Chembio Diagnostics Enters Into Licensing Agreement With RVR Diagnostics 11
Genisphere Enters Into Licensing Agreement With Chembio Diagnostics 11
Chembio Diagnostics Enters into Agreement with FIND 12
Chembio Diagnostics Enters into Co-Development Agreement with Bio-Manguinhos 13
Chembio Diagnostics Enters into Agreement with Perseus Science 13
Chembio Diagnostics Enters into Co-Development Agreement with Integrated BioTherapeutics 14
Chembio Diagnostics Enters into Agreement to Develop POC Diagnostic Tests for Dengue Fever Virus and Specific Type of Cancer 15
Chembio Enters Into Distribution Agreement With Labtest For Dual Path Platform Products 16
Equity Offering 17
Chembio Diagnostics Raises USD13.8 Million in Public Offering of Shares 17
Chembio Diagnostics Completes Public Offering Of Common Stock For US$6 Million 18
Acquisition 19
Chembio Diagnostics Acquires RVR Diagnostics 19
Chembio Diagnostics Inc - Key Competitors 21
Key Employees 22
Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Financial Announcements 24
Mar 07, 2017: Chembio Diagnostics Reports 2016 Financial Results 24
Nov 10, 2016: Chembio Diagnostics Reports Third Quarter 2016 Financial Results 27
Aug 11, 2016: Chembio Diagnostics Reports Second Quarter 2016 Financial Results 30
Jul 25, 2016: Chembio Diagnostics Announces Preliminary Second Quarter 2016 Results 33
May 12, 2016: Chembio Diagnostics Reports First Quarter 2016 Financial Results 34
Mar 08, 2016: Chembio Diagnostics Reports 2015 Financial Results 36
Corporate Communications 38
Jan 26, 2017: Chembio Appoints Sales Executives in Latin America, Africa, Asia Pacific 38
Oct 11, 2016: Chembio Expands Global Commercial Operations Leadership 39
Other Significant Developments 40
Sep 23, 2016: Chembio Expands Exclusive Distribution Agreements with Isla Lab to Include Puerto Rico and U.S. Virgin Islands 40
Aug 25, 2016: Chembio Awarded Up to $13.2 Million U.S. Government Contract to Develop and Commercialize Point-of-Care Tests for Zika Virus 41
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42
List of Tables
Chembio Diagnostics Inc, Medical Equipment, Key Facts, 2015 1
Chembio Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
Chembio Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Chembio Diagnostics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Chembio Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Chembio Diagnostics Inc, Deals By Market, 2011 to YTD 2017 9
Chembio Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Chembio Diagnostics Enters Into Licensing Agreement With RVR Diagnostics 11
Genisphere Enters Into Licensing Agreement With Chembio Diagnostics 11
Chembio Diagnostics Enters into Agreement with FIND 12
Chembio Diagnostics Enters into Co-Development Agreement with Bio-Manguinhos 13
Chembio Diagnostics Enters into Agreement with Perseus Science 13
Chembio Diagnostics Enters into Co-Development Agreement with Integrated BioTherapeutics 14
Chembio Diagnostics Enters into Agreement to Develop POC Diagnostic Tests for Dengue Fever Virus and Specific Type of Cancer 15
Chembio Enters Into Distribution Agreement With Labtest For Dual Path Platform Products 16
Chembio Diagnostics Raises USD13.8 Million in Public Offering of Shares 17
Chembio Diagnostics Completes Public Offering Of Common Stock For US$6 Million 18
Chembio Diagnostics Acquires RVR Diagnostics 19
Chembio Diagnostics Inc, Key Competitors 21
Chembio Diagnostics Inc, Key Employees 22
Chembio Diagnostics Inc, Subsidiaries 23
List of Figures
Chembio Diagnostics Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
Chembio Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
Chembio Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
Chembio Diagnostics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
Chembio Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Chembio Diagnostics Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 7
Chembio Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Chembio Diagnostics Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 9
